Hims & Hers Health plans to offer generic version of Novo Nordisk's drug
2024-11-05Business Standard
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier for this addition and over the next few months exp Read more
